Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | VRNS | CPA |
|---|---|---|
| Price | $48.15 | $135.51 |
| Change today | ▲ 1.22% | ▲ 2.29% |
| Market cap | $5.53B | $5.53B |
| Return, 3 months | +5.0% | -8.0% |
| Return, year to date | +46.8% | +16.6% |
| Return, 1 year | -20.7% | +17.8% |
| P/E (TTM) | -39.5 | 8.9 |
| P/B | 12.4 | 1.9 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | 4.90% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 58 | 57 |
| 30-day volatility | 47.1% | 29.1% |
| Max drawdown, 1 year | -68.1% | -29.2% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
